QUICK ANSWER
The Anti-Nuclear Ab by IFA (RDL) is a blood test that detects antinuclear antibodies — immune proteins that target the body's own cell nuclei. It is used as a screening test for autoimmune conditions, particularly connective tissue diseases.
Two things to know immediately:
- "RDL" is not a result — it identifies LabCorp's RDL rheumatology testing platform. It appears in the test name because this test is processed through that platform. It has no clinical meaning.
- A positive result does not mean you have lupus — low-titer positive ANA is common in healthy individuals. Titer, pattern, symptoms, and specific antibody results all determine clinical significance.
| Result on your report | What it means |
|---|---|
| Negative | No ANA detected above the reporting threshold — expected result for most people |
| Positive | ANA detected — requires interpretation of titer and pattern; does not diagnose any specific disease by itself |
| Positive Abnormal | Same as Positive — "Abnormal" is the lab flag indicating the result is outside the reference interval (Negative) |
| WarningAbnormal | The HealthMatters dashboard label for a Positive ANA result — reflects the alert classification, not medical urgency |
Common questions at a glance:
| Question | Short answer |
|---|---|
| What does "RDL" mean in my blood test? | LabCorp's RDL rheumatology testing platform — a lab identifier, not a result type |
| What does positive ANA mean? | Antinuclear antibodies were detected; titer, pattern, and symptoms determine significance |
| Does a positive ANA mean I have lupus? | Not by itself — positive ANA is common in healthy people; lupus requires multiple criteria beyond a positive ANA |
| What is a normal ANA result? | Negative — no antinuclear antibodies detected above the reporting threshold |
| What does "WarningAbnormal" mean on HealthMatters? | The ANA was positive (above reference interval); "Warning" is the dashboard alert level, not a measure of medical urgency |
WHAT IS "RDL" IN MY BLOOD TEST? — THE MOST IMPORTANT DECODER
The "(RDL)" in "Anti-Nuclear Ab by IFA (RDL)" does not describe your result. It is a laboratory platform identifier.
RDL refers to LabCorp's RDL rheumatology testing platform — a specialized testing infrastructure that LabCorp built on the foundation of RDL Reference Laboratory. When LabCorp processes ANA testing by indirect fluorescent antibody (IFA) method, it routes this testing through the RDL platform. LabCorp appends the platform identifier to the test name, which is why you see "(RDL)" in the name on your report and in HealthMatters.
| What "(RDL)" means | What "(RDL)" does NOT mean |
|---|---|
| LabCorp's RDL rheumatology testing platform | A type of result (it is not a result category) |
| Identifies the testing platform used for this assay | A severity level or warning |
| Appears on LabCorp reports for tests processed through the RDL platform | Anything about whether your result is positive or negative |
Why does this matter? Because many users search "what is RDL in blood test" or "RDL positive" believing RDL is a clinical finding. It is not. Your clinical result is the Positive or Negative designation — RDL only tells you which platform analyzed the sample.
Other LabCorp tests that use similar platform identifiers include tests labeled "(RDL)" for rheumatology assays or "(LC)" for tests performed on LabCorp's own platform. The identifier in parentheses is always the performing lab or platform, never the result.
WHAT DOES "WARNINGABNORMAL" MEAN ON HEALTHMATTERS?
If your HealthMatters dashboard shows "WarningAbnormalAnti-Nuclear Ab by IFA (RDL)" or "Abnormal Anti-Nuclear Ab by IFA (RDL)", this means:
- Your ANA result was Positive (above the reference interval, which is Negative)
- The HealthMatters system flagged it with a Warning alert level
- The word "Warning" reflects the alert classification in the dashboard — it does not mean the result is medically dangerous or requires emergency action
Which part of "WarningAbnormalAnti-Nuclear Ab by IFA (RDL) Positive" is my actual result?
The actual result is Positive. Here is what each component means:
- Warning = HealthMatters alert level for an above-range result
- Abnormal = the result is outside the reference interval (Negative)
- Anti-Nuclear Ab by IFA = the test name
- (RDL) = the LabCorp/RDL testing platform identifier
- Positive = your clinical result
The clinical interpretation depends on the ANA titer, pattern, symptoms, and follow-up antibody results — not on the dashboard label.
WHAT DOES A POSITIVE ANA MEAN?
A positive Anti-Nuclear Ab by IFA result means antinuclear antibodies were detected in your blood above the reporting threshold. ANA are proteins produced by the immune system that target structures within the nucleus of cells.
A positive ANA alone does not diagnose any specific disease. It is a screening test. The clinical significance of a positive ANA depends on:
| Factor | Why it matters |
|---|---|
| Titer level | Low titers (1:40, 1:80) are common in healthy individuals; higher titers are more likely to be clinically significant |
| Fluorescence pattern | Different patterns suggest different possible underlying antibodies and associated conditions |
| Symptoms | A positive ANA with no symptoms has different significance than a positive ANA with joint pain, rash, and fatigue |
| Specific antibody results | Tests such as anti-dsDNA, anti-Smith, anti-SSA/SSB are more diagnostically specific than ANA alone |
| Clinical context | Age, sex, medications, and family history all affect interpretation |
How common is a positive ANA in healthy people? In a landmark study by Tan et al., ANA was detectable in healthy individuals at these rates: 31.7% at 1:40, 13.3% at 1:80, 5.0% at 1:160, and 3.3% at 1:320. This is why titer matters — a 1:40 positive is found in nearly one in three healthy adults.
What symptoms make a positive ANA more meaningful? Not all symptoms are equally specific. Symptoms that make a positive ANA clinically more significant include: persistent inflammatory joint swelling, photosensitive rash (especially butterfly/malar rash), mouth ulcers, Raynaud's phenomenon, unexplained low blood counts, protein or blood in the urine, pleuritic chest pain, dry eyes and dry mouth, skin thickening, or recurrent unexplained fevers. Fatigue alone is common and nonspecific for autoimmune disease.
YOUR ANA TITER — WHAT DOES YOUR NUMBER MEAN?
When an ANA is positive, the lab reports a titer — a dilution ratio reflecting the concentration of antinuclear antibodies. The higher the titer, the more concentrated the antibodies. LabCorp reports ANA starting at 1:40 or 1:80 depending on the test option ordered.
| ANA titer | Prevalence in healthy adults (Tan et al.) | Interpretation |
|---|---|---|
| Negative | — | No ANA detected above reporting threshold — standard negative result |
| 1:40 | ~31.7% of healthy adults | Very low positive; extremely common in healthy people; often incidental; low clinical significance in isolation |
| 1:80 | ~13.3% of healthy adults | Low positive; common in healthy people; used as the entry threshold in 2019 EULAR/ACR SLE classification criteria, but not diagnostic by itself |
| 1:160 | ~5.0% of healthy adults | More clinically meaningful; found in fewer healthy individuals; warrants evaluation of pattern and specific antibody results |
| 1:320 | ~3.3% of healthy adults | Higher positive; less common in healthy people; more concerning when accompanied by symptoms |
| 1:640 | Much less common | High positive — clinical significance depends strongly on symptoms and specific antibody results |
| 1:1280 and above | Uncommon in healthy adults | Very high positive — more likely to be clinically significant, especially with symptoms; rheumatology evaluation appropriate; note that titer alone does not prove active disease |
What does 1:40 mean? A titer of 1:40 means antibodies were detectable when serum was diluted 40-fold. This is the lowest reportable positive threshold on many assays and is found in nearly one in three healthy adults. A 1:40 ANA in an asymptomatic person is usually not clinically significant.
What does 1:80 mean? 1:80 is important because it is the entry threshold used in the 2019 EULAR/ACR SLE classification criteria — meaning 1:80 on HEp-2 IFA is required before the classification system is even applied. However, 1:80 is found in approximately 13% of healthy adults and is not diagnostic of lupus or any autoimmune disease on its own.
What does 1:160 and above mean? Titers of 1:160 and higher are present in fewer healthy individuals (~5% at 1:160) and carry increasing clinical significance when accompanied by relevant symptoms or specific antibody abnormalities.
ANA FLUORESCENCE PATTERN — WHAT YOUR PATTERN MEANS
A positive ANA by IFA also reports a fluorescence pattern — the appearance of ANA staining on HEp-2 cells under a fluorescent microscope. Different patterns suggest possible underlying antibodies and associated conditions.
Important: ANA patterns are general clues, not diagnoses. LabCorp specifically notes that ANA patterns on HEp-2 slides provide only general clues and, except for centromere pattern, are not reliably correlated with specific antibodies. Specific antibody testing is required to identify which antibody is actually present.
| Pattern | Possible associated antibodies / follow-up tests | Conditions to consider |
|---|---|---|
| Homogeneous (Diffuse) | Anti-dsDNA, anti-histone, anti-chromatin/nucleosome | Systemic lupus erythematosus (SLE), drug-induced lupus |
| Speckled | Anti-SSA/Ro, anti-SSB/La, anti-Smith, anti-U1 RNP, other ENA antibodies | Sjögren's syndrome, SLE, mixed connective tissue disease (MCTD), overlap syndromes |
| Nucleolar | Anti-Scl-70 (topoisomerase I), anti-RNA polymerase III, anti-PM-Scl | Systemic sclerosis (scleroderma) spectrum |
| Centromere | Anti-centromere antibody — centromere pattern is more reliably correlated with anti-centromere antibodies than other patterns | Limited systemic sclerosis (CREST syndrome) |
| Nuclear dots | Anti-Sp100, anti-PML | Primary biliary cholangitis, sometimes incidental |
| Cytoplasmic | Anti-Jo-1, anti-mitochondrial | Polymyositis/dermatomyositis, primary biliary cholangitis |
What does "speckled pattern" mean? The speckled pattern is the most common positive ANA pattern. It indicates antibodies targeting proteins distributed throughout the nucleus. Multiple specific antibodies can produce a speckled pattern — including anti-SSA/Ro (Sjögren's), anti-SSB/La (Sjögren's), anti-Smith (lupus), and anti-U1 RNP (MCTD). Specific antibody testing is required to determine which one is present. A speckled pattern at low titer (1:40–1:80) with no symptoms is common and usually not clinically significant.
What does "homogeneous pattern" mean? The homogeneous (diffuse) pattern shows uniform nuclear staining. It is classically associated with SLE (anti-dsDNA) and drug-induced lupus (anti-histone), but is also seen in healthy individuals at low titers. A homogeneous pattern with high titer and symptoms would typically prompt anti-dsDNA and complement level (C3/C4) testing.
THE ANA 12 PLUS PROFILE (RDL) — WHAT IS THIS PANEL?
If your HealthMatters dashboard shows "ANA 12 Plus Profile (RDL)" or "ANA 12 Plus Profile Do All (RDL)", this refers to LabCorp test code 520180 — a reflexive autoimmune panel.
How the ANA 12 Plus Profile works:
- The panel starts with the ANA by IFA screen
- If ANA is positive, LabCorp automatically performs the full reflex profile of specific antibody and complement tests
- If ANA is negative, Anti-Ro/SS-A testing is still performed — because a small percentage of cases with Ro antibodies may have a negative or low ANA by IFA
Components of the ANA 12 Plus Profile (LabCorp 520180):
| Component | Why it matters |
|---|---|
| Anti-Nuclear Ab by IFA (RDL) | ANA screen — the starting test; includes titer and pattern |
| Anti-dsDNA Ab (by Farr method) | Highly specific for SLE; correlates with disease activity |
| Anti-Smith (Sm) Ab | Highly specific for SLE; diagnostic when positive |
| Anti-U1 RNP Ab | Mixed connective tissue disease and overlap syndromes |
| Anti-Ro/SS-A Ab | Sjögren's syndrome, neonatal lupus, SLE; also performed when ANA is negative |
| Anti-La/SS-B Ab | Sjögren's syndrome, SLE context |
| Anti-Scl-70 (Topoisomerase I) Ab | Diffuse systemic sclerosis (scleroderma) |
| Anti-Centromere Ab | Limited systemic sclerosis (CREST syndrome) |
| Anti-Chromatin Ab, IgG | SLE, drug-induced lupus context |
| Anti-TPO Ab | Autoimmune thyroid disease — may coexist with connective tissue disease |
| C3 Complement | Lupus disease activity; reduced by immune complex consumption |
| C4 Complement | Lupus disease activity; reduced by immune complex consumption |
| Rheumatoid Factor by Turbidimetry | Rheumatoid arthritis and overlap context |
| Anti-CCP Ab | Rheumatoid arthritis specificity |
| Anticardiolipin IgG, IgA, IgM | Antiphospholipid syndrome context |
"Do All" vs. reflexive: "ANA 12 Plus Profile Do All (RDL)" means all components were ordered simultaneously regardless of the ANA screening result, rather than waiting for a positive ANA to trigger the reflex tests. This is done when comprehensive autoimmune screening is wanted immediately.
HOW THE ANA REFLEX CASCADE WORKS
A positive ANA by IFA typically triggers reflex testing — additional specific antibody tests ordered automatically when the screening result is positive. This is why a single blood draw may produce multiple additional results.
| ANA result | What typically happens next |
|---|---|
| Negative | Anti-Ro/SS-A still performed (in ANA 12 Plus Profile); otherwise no reflex |
| Positive at 1:40–1:80 | Reflex antibody panel triggered depending on the ordering panel |
| Positive at 1:80 or above | Full reflex antibody panel typically triggered |
| Positive + Speckled pattern | Anti-SSA/Ro, anti-SSB/La, anti-Smith, anti-RNP most relevant follow-up |
| Positive + Homogeneous pattern | Anti-dsDNA, anti-histone, anti-chromatin most relevant follow-up |
| Positive + Nucleolar pattern | Anti-Scl-70, anti-RNA polymerase III, anti-PM-Scl most relevant follow-up |
| Positive + Centromere pattern | Anti-centromere antibody; limited scleroderma evaluation |
WHAT DOES A NEGATIVE ANA MEAN?
A negative Anti-Nuclear Ab by IFA result means no antinuclear antibodies were detected above the reporting threshold. This is the expected, normal result and is highly reassuring in most clinical contexts. The ANA by IFA test has high sensitivity for most ANA-associated rheumatic conditions — particularly lupus, where approximately 95% of cases have a positive ANA.
A negative ANA makes most ANA-associated autoimmune diseases unlikely, but rare exceptions exist:
| Situation | Notes |
|---|---|
| Negative ANA with lupus symptoms | Rare (~5% of lupus cases); anti-dsDNA or anti-Smith may still be positive |
| Negative ANA on the ANA 12 Plus Profile | Anti-Ro/SS-A is still performed because a small percentage of Ro-positive cases have negative ANA by IFA |
| Negative ANA with scleroderma features | Anti-Scl-70 can occasionally be present with low or negative ANA |
| Negative ANA on immunosuppressive therapy | Medications may suppress ANA to undetectable levels |
WHAT IF MY ANA IS POSITIVE BUT ALL SPECIFIC ANTIBODIES ARE NEGATIVE?
This is a very common and often anxiety-provoking situation. A positive ANA — especially at low titer — with negative specific antibody tests (negative anti-dsDNA, anti-Smith, anti-SSA/SSB, anti-Scl-70, etc.) has low predictive value for most autoimmune rheumatic diseases.
Several things can explain this pattern:
| Explanation | What it means |
|---|---|
| Low-titer incidental positive | 1:40 or 1:80 ANA with negative specific antibodies in an asymptomatic person is very likely incidental and not clinically significant |
| Anti-DFS70 pattern | Anti-DFS70 (dense fine speckled 70) antibody is associated with a characteristic ANA pattern and — when present in isolation without other specific antibodies — is associated with a lower likelihood of systemic autoimmune rheumatic disease. If suspected, specific DFS70 antibody testing can be ordered |
| Antibodies not included in the panel | Some autoimmune conditions involve antibodies not routinely tested (e.g., anti-MDA5, anti-TIF1-gamma in myositis); specialist evaluation may be needed |
| Early or evolving disease | Specific antibodies may develop later; clinical follow-up is warranted if symptoms progress |
A positive ANA with all negative specific antibodies and no symptoms is not a diagnosis of any autoimmune disease and usually does not require immediate action beyond clinical correlation.
MOST COMMON CLINICAL SCENARIOS
| Pattern | Most likely interpretation | Recommended next step |
|---|---|---|
| Negative ANA + no symptoms | Expected result — no autoimmune disease suggested | Routine monitoring |
| Positive ANA 1:40 + no symptoms | Common incidental finding; found in ~32% of healthy adults | Clinical correlation; repeat if symptoms develop |
| Positive ANA 1:80 + no symptoms | Low positive — common; 1:80 is EULAR/ACR SLE entry threshold but not diagnostic | Discuss with doctor; no action usually needed without symptoms |
| Positive ANA 1:160+ + joint swelling, rash, or fatigue with objective findings | Clinically significant positive with specific symptoms | Reflex antibody panel; rheumatology evaluation |
| Positive ANA + speckled pattern + dry eyes and dry mouth | Sjögren's pattern | Anti-SSA/Ro, anti-SSB/La testing; rheumatology referral |
| Positive ANA + homogeneous pattern + butterfly rash | Lupus pattern | Anti-dsDNA, complement levels (C3/C4), anti-Smith |
| Positive ANA + centromere pattern + Raynaud's | CREST/limited scleroderma pattern | Rheumatology evaluation; confirm with anti-centromere antibody |
| Positive ANA + nucleolar pattern + skin thickening | Diffuse scleroderma pattern | Anti-Scl-70, anti-RNA polymerase III; rheumatology |
| Positive ANA + normal ESR/CRP + no specific symptoms | Often incidental, especially at low titer | Clinical correlation; avoid overdiagnosis |
| Positive ANA + low C3/C4 + positive dsDNA | Lupus pattern, especially with symptoms | Prompt rheumatology evaluation |
| Positive ANA + all specific antibodies negative | Common; low predictive value especially at low titer | Reassure if asymptomatic; consider DFS70 testing; follow if symptoms develop |
| Positive ANA + thyroid antibodies (anti-TPO) positive | Autoimmune thyroid disease may coexist | Thyroid evaluation; interpret ANA separately for rheumatic disease |
| Positive ANA + medications (procainamide, hydralazine, minocycline) | Drug-induced lupus-like syndrome possible | Discuss medication history with doctor; anti-histone antibody |
| Positive ANA 12 Plus Profile with multiple specific antibodies positive | Significant autoimmune panel | Rheumatology evaluation required |
WHEN SHOULD I WORRY ABOUT A POSITIVE ANA?
| Situation | Concern level | Recommended action |
|---|---|---|
| Positive ANA 1:40 or 1:80 + no symptoms + no specific antibodies | Low | Discuss with doctor; likely incidental; recheck if symptoms develop |
| Positive ANA + nonspecific symptoms only (fatigue, mild aches) + low titer | Low-Moderate | Discuss with doctor; evaluate common non-autoimmune causes too |
| Positive ANA + specific autoimmune features (joint swelling, rash, dry eyes) | Moderate | Rheumatology referral usually appropriate |
| Positive ANA 1:160+ + objective symptoms or signs | Moderate-High | Reflex antibody panel + rheumatology evaluation |
| Positive ANA + positive dsDNA/Sm + low complements + kidney findings | High | Prompt rheumatology evaluation; possible lupus |
| Positive ANA + positive anti-Scl-70 or anti-centromere | Moderate-High | Rheumatology; evaluate for scleroderma spectrum |
| Positive ANA + positive anticardiolipin or anti-U1 RNP | Moderate | Rheumatology evaluation for antiphospholipid syndrome or MCTD |
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Frequently Asked Questions
What does "RDL" mean in my blood test result?
Which part of "WarningAbnormalAnti-Nuclear Ab by IFA (RDL) Positive" is my actual result?
What does "Anti-Nuclear Ab by IFA (RDL) Positive" mean?
Does a positive ANA mean I have lupus?
What does "WarningAbnormal" mean on my HealthMatters dashboard?
What does the ANA titer mean?
What does a speckled ANA pattern mean?
What does a homogeneous ANA pattern mean?
What is the ANA 12 Plus Profile (RDL)?
What if my ANA is positive but all my specific antibodies are negative?
Should I repeat a positive ANA test?
Can a positive ANA go away or become negative?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Range of antinuclear antibodies in "healthy" individuals
-
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
-
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
-
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases